Shen Hongbing

发布者:公共卫生学院发布时间:2022-10-23浏览次数:693

Member oChinese Academy of Engineering

Professor of  Epidemiology, School of Public Health

Director oChinese Center for Disease Control and Prevention

Deputy Director oNational Bureau of  Disease Control and Prevention

Director of China International Cooperation Center for Environment and Human Health

Director of Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment

Director of Collaborative Innovation Center for Cancer Personalized Medicine

hbshen@njmu.edu.cn

沈洪兵,中国工程院院士,博士教授

Hongbing  Shen, Academician, MD, PhD



Research Interest

Environment and Molecular Epidemiology on Complex diseases

Biomarkers for cancer susceptibility, molecular subtyping, and precision diagnosis

 

Education

Nanjing Medical College (currently Nanjing Medical University), Public Health, B.Med. (1981.9-1986.7)

Nanjing Medical College (currently Nanjing Medical University), Epidemiology, M.S. (1986.9-1989.7)

Shanghai Medical University (currently Fudan University), Epidemiology, Ph.D.(1996.9-1999.7)

The University of  Texas, MD Anderson Cancer Center, USA, Epidemiology, Postdoctoral Fellow (1999.12-2002.2)


HonorS and Awards:

2004  National Science Fund for Distinguished Young Scholars, China

2008  Natural Science and Technology Prize (First Class), the Ministry of  Education of China

2009  “Chang-Jiang Scholar Professor”, Ministry of  Education of China

2010  Natural Science and Technology Prize (Second Class),The Ministry of  Education of China

2013  State Natural Science Award (Second Class) ,The State Council of  China

2014  National Teaching Achievement Awards (Second Class),Ministry of  Education

2014  Natural Science Award(First Class), Ministry of  Education

2015  State Scientific and Technological Progress Award (Second Class)

2016  Ho Leung Ho Lee Foundation Science and Technology Progress  Award

2018  State Natural Science Award (Second Class), The State Council of  China


Ongoing Research Projects

  • PI, Systematic toxicological and epidemiological study on health hazards of fine particulate matter, NSFC, 91943301

  • PI, Gene-environment interaction and genomic epidemiology of lung cancer, NSFC, 81820108028

  • PI, Research Unit of  Prospective Cohort of Cardiovascular Diseases and Cancers, Chinese Academy of  Medical Sciences,2019RU038


Selected Papers

  1. Huang Y†,Zhu M†, Ji M, Fan J, Xie J, Wei X, Jiang X, Xu J, Chen L, Yin R,Wang Y, Dai J, Jin G, Xu L, Hu Z, Ma H*, Shen H. Air Pollution, Genetic Factors, and the Risk of  Lung Cancer: A Prospective Study in the UK Biobank. Am J Respir Crit Care Med. 2021Oct 1;204(7):817-825.

  2. Zhu M†,Wang T†, Huang Y, Zaho X, Ding Y, Zhu M, Ji M, Wang C, Dai J, YinR, Xu L, Ma H, Wei Q, Jin G*, Hu Z*, Shen H*. Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle. Cancer Res. 2021 Sep 1;81(17):4618-4627.

  3. Wang C†,Lv H†, Ling X†, Li H†, Diao F†, Dai J, Du J, Chen T, Xi Q,Zhao Y, Zhou K, Xu B, Han X, Liu X, Peng M, Chen C, Tao S, Huang L,Liu C, Wen M, Jiang Y, Jiang T, Lu C, Wu W, Wu D, Chen M, Lin Y, GuoX, Huo R, Liu J, Ma H, Jin G, Xia Y, Sha J, Shen H*.Association of assisted reproductive technology, germline de novo mutations and congenital heart defects in a prospective birth cohort study. Cell Res. 2021 Aug;31(8):919-928.

  4. Jin G†,Lv J†, Yang M†, Wang M†, Zhu M†, Wang T†, Yan C, Yu C,Ding Y, Li G, Ren C, Ni J, Zhang R, Guo Y, Bian Z, Zheng Y, Zhang N,Jiang Y, Chen J, Wang Y, Xu D, Zheng H, Yang L, Chen Y, Walters R,Millwood IY, Dai J, Ma H, Chen K, Chen Z, Hu Z, Wei Q*,Shen H*,Li L*. Genetic risk, incident gastric cancer, and healthy lifestyle:a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol.2020 Oct; 21(10):1378-1386.

  5. Qin N,Ma Z,Wang C,Zhang E, Li Y, Huang M, Chen C, Zhang C, Fan J, Gu Y, Xu X, Yang L,Wei X, Yin R, Jiang Y, Dai J, Jin G, Xu L, Hu Z*, Shen H*, Ma H*.Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype. Theranostics. 2020 Sep 14;10(24):11264-11277.

  6. Dai J†,Lv J†, Zhu M†, Wang Y†, Qin N†, Ma H†, He YQ†, Zhang R†,Tan W, Fan J, Wang T, Zheng H, Sun Q, Wang L, Huang M, Ge Z, Yu C,Guo Y, Wang TM, Wang J, Xu L, Wu W, Chen L, Bian Z, Walters R,Millwood IY, Li XZ, Wang X, Hung RJ, Christiani DC, Chen H, Wang M,Wang C, Jiang Y, Chen K, Chen Z, Jin G, Wu T, Lin D, Hu Z*, AmosCI*, Wu C*, Wei Q*, Jia W*, Li L*, Shen H*. Identification of risk loci and a risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir Med. 2019 Oct;7(10):881-891.